首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems
【2h】

Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems

机译:开发适体功能的靶向药物递送系统的进展和挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aptamers, which can be screened via systematic evolution of ligands by exponential enrichment (SELEX), are superior ligands for molecular recognition due to their high selectivity and affinity. The interest in the use of aptamers as ligands for targeted drug delivery has been increasing due to their unique advantages. Based on their different compositions and preparation methods, aptamer-functionalized targeted drug delivery systems can be divided into two main categories: aptamer-small molecule conjugated systems and aptamer-nanomaterial conjugated systems. In this review, we not only summarize recent progress in aptamer selection and the application of aptamers in these targeted drug delivery systems but also discuss the advantages, challenges and new perspectives associated with these delivery systems.
机译:可以通过指数富集(SELEX)通过配体的系统进化来筛选的适体,由于它们的高选择性和亲和力,是用于分子识别的优良配体。由于其独特的优势,对于将适体用作靶向药物递送的配体的兴趣已经增加。基于它们的不同组成和制备方法,适体功能化的靶向药物递送系统可分为两大类:适体-小分子结合系统和适体-纳米材料结合系统。在这篇综述中,我们不仅总结了适体选择和适体在这些靶向药物递送系统中的应用的最新进展,而且还讨论了与这些递送系统相关的优势,挑战和新观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号